WHO ICTRP trial

Double-blind parallel study of Omega-3 fatty acid supplement in patients with…

ISRCTN14235435 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN14235435
Public title Double-blind parallel study of Omega-3 fatty acid supplement in patients with refractory epilepsy
Primary sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Countries United Kingdom
Conditions Nervous System Diseases: Epilepsy Nervous System Diseases Epilepsy
Interventions 1. Omega-3 fatty acid 2. Olive oil
Registration date Dec 9, 2003
Target size 52
Secondary IDs N0263120045
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations